Vamo Devon
Analyst
Guggenheim Securities
Equibles does not estimate personal net worth.
About Vamo Devon
Vamo Devon is recorded as Analyst at Guggenheim Securities. Vamo Devon has spoken on 2 earnings calls and 4 other investor events across 6 companies, most recently for Tonix Pharmaceuticals Holding Corp. on November 10, 2026. Those appearances were for Tonix Pharmaceuticals Holding Corp. (TNXP), iBio, Inc. (IBIO), Eloxx Pharmaceuticals, Inc. (ELOX), Rein Therapeutics, Inc. (RNTX), Johnson & Johnson (JNJ) and 1 other company. The companies whose calls Vamo Devon spoke on are classified in the Healthcare sector.
Vamo Devon on recent calls
“Thanks so much, everyone, for joining us this year for the Guggenheim Healthcare Innovation Conference. I'm Vamo Devon, one of the biopharma analysts here. Next up here in this room, we have Tonics Pharmaceuticals, and I'm joined by Seth Liederman, the CEO of the company.”
“Thanks, everyone, again, for joining us for this year's Guggenheim Healthcare Innovation Conference on day two here today. Vamo Devon, one of the biopharm analysts here from Guggenheim, joined on the Guggenheim side up here on stage by Daniel Krizay from the team.”
“Joined up on the stage on the Guggenheim side, Arsini Chavezvili from the team. And next in this room, we have the ELOX Pharmaceuticals team. Next to me is Sumit Agarwal, CEO, and John Wolford, the Vice President of Corporate Development.”
“Thanks again, everyone, for joining us at the Guggenheim Healthcare Innovation Conference again this year. I'm Vamo Devon, one of the biopharm analysts here, joined on the stage from the Guggenheim side by Daniel Crozet from the team.”
“Maybe one just follow-up and then one actual question. Following up on the IcoTide, I appreciate the comments you've made so far. Just curious if you would be willing to provide any commentary around the actual net sales in the quarter or kind of how it compares to where consensus was.”
Affiliation history
-
Guggenheim Securities
Analyst
Transcript header (unverified)
Current
Company network
IBIO
Biotechnology · Healthcare
Drug Manufacturers - General · Healthcare
ABBV
Drug Manufacturers - General · Healthcare